Market Research Logo

CRISPR and CAS Gene Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

CRISPR and CAS Gene Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and CRISPR-associated (Cas) genes are essential for the adaptive immunity in few bacteria and archaea, enabling the organisms to respond to and to eliminate invading genetic material. These gene editing tools are extensively used in agriculture and food security.

Many food and agricultural organizations are working on receiving license for using CRISPR and CAS gene technology for creating novel products in food and agriculture business. For instance, in September 2016, agrochemical and agricultural biotechnology corporation Monsanto secured a worldwide non-exclusive license agreement for agricultural applications of CRISPR technology from the Broad Institute. CRISPR and CAS genes are also used in treating a number of diseases such as cancer, blood disorders, AIDS, and genetic disorders such as cystic fibrosis, Huntington’s etc.

Market Dynamics

Increasing prevalence of genetic disorders such as Down’s syndrome, sickle cell anaemia, and Huntington’s disease worldwide is highly contributing to the market growth of CRISPR and CAS gene market, as many genetic disabilities can be corrected using this gene editing technology. According to National Health Service (NHS) U.K. 2018 report, the highest rate of Huntington’s disease in the United Kingdom is 12 per 100,000 people. Also, in the U.S., an estimated 10 per 100,000 have the faulty Huntington’s gene and live either waiting for symptoms to begin or live/struggle with the disease.

Government bodies are taking initiatives for developing treatment of Huntington’s disease. For instance, in 2016, US-based Company Addgene has developed the KamiCas9, a version of CRISPR-Cas9 that includes a ‘self-inactivating’ KamiCas9 system for the editing of CNS disease genes for treatment of Huntington’s disease.

However, the CRISPR and CAS gene market growth is hindered by the ethical issues, which is the major concern for every gene therapy. For instance, in April 2015, the US National Institutes of Health issued a statement indicating that it will not fund any research that uses genome editing tools such as CRISPR in human embryos due to ethical issues.

Key features of the study:

  • This report provides in-depth analysis of the CRISPR and CAS Gene market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2019 – 2026, considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global CRISPR and CAS Gene market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Caribou Biosciences Inc., CRISPR Therapeutics, Mirus Bio LLC, Editas Medicine, Takara Bio Inc., Synthego, Thermo Fisher Scientific, Inc., GenScript, Addgene, Merck KGaA (Sigma-Aldrich), Integrated DNA Technologies, Inc., Transposagen Biopharmaceuticals, Inc., OriGene Technologies, Inc., New England Biolabs, Dharmacon, Cellecta, Inc., Agilent Technologies, and Applied StemCell, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global CRISPR and CAS Gene market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for CRISPR and CAS Gene market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
  • Global CRISPR and CAS Gene Market, By Product Type:
  • Vector-based Cas
  • DNA-free Cas
  • Global CRISPR and CAS Gene Market, By Application:
  • Genome Engineering
  • Disease models
  • Functional Genomics
  • Knockdown/activation
  • Other Applications
  • Global CRISPR and CAS Gene Market, By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Contract Research Organizations
  • Global CRISPR and CAS Gene Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Product Type:
  • Vector-based Cas
  • DNA-free Cas
  • By Application:
  • Genome Engineering
  • Disease models
  • Functional Genomics
  • Knockdown/activation
  • Other Applications
  • By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Contract Research Organizations
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Product Type:
  • Vector-based Cas
  • DNA-free Cas
  • By Application:
  • Genome Engineering
  • Disease models
  • Functional Genomics
  • Knockdown/activation
  • Other Applications
  • By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Contract Research Organizations
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Product Type:
  • Vector-based Cas
  • DNA-free Cas
  • By Application:
  • Genome Engineering
  • Disease models
  • Functional Genomics
  • Knockdown/activation
  • Other Applications
  • By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Contract Research Organizations
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Product Type:
  • Vector-based Cas
  • DNA-free Cas
  • By Application:
  • Genome Engineering
  • Disease models
  • Functional Genomics
  • Knockdown/activation
  • Other Applications
  • By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Contract Research Organizations
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Product Type:
  • Vector-based Cas
  • DNA-free Cas
  • By Application:
  • Genome Engineering
  • Disease models
  • Functional Genomics
  • Knockdown/activation
  • Other Applications
  • By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Contract Research Organizations
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • By Product Type:
  • Vector-based Cas
  • DNA-free Cas
  • By Application:
  • Genome Engineering
  • Disease models
  • Functional Genomics
  • Knockdown/activation
  • Other Applications
  • By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Contract Research Organizations
  • Company Profiles
  • Caribou Biosciences Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • CRISPR Therapeutics
  • Mirus Bio LLC
  • Editas Medicine
  • Takara Bio Inc.
  • Synthego Corporation
  • Thermo Fisher Scientific, Inc.
  • GenScript
  • Addgene
  • Merck KGaA (Sigma-Aldrich)
  • Integrated DNA Technologies, Inc.
  • Transposagen Biopharmaceuticals, Inc.
  • OriGene Technologies, Inc.
  • New England Biolabs
  • Dharmacon, Cellecta, Inc.
  • Agilent Technologies
  • Applied StemCell, Inc.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Landscape
Epidemiology Analysis
Technology Overview
PEST Analysis
Porter’s Five Forces model
4. Global CRISPR and CAS Gene Market, By Product Type, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Vector-based Cas
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
DNA-free Cas
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
5. Global CRISPR and CAS Gene Market, By Application, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Genome Engineering
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Disease models
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Functional Genomics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Knockdown/activation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Other Applications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
6. Global CRISPR and CAS Gene Market, By End User, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Biotechnology and Pharmaceutical Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Academic and Government Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Contract Research Organizations
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
7. Global CRISPR and CAS Gene Market, By Region, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2017 – 2026
Regional Trends
North America
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
8. Competitive Landscape
Company Profiles
Caribou Biosciences Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
CRISPR Therapeutics
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Mirus Bio LLC
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Editas Medicine
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Takara Bio Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Synthego Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Thermo Fisher Scientific, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
GenScript
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Addgene
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Merck KGaA (Sigma-Aldrich)
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Integrated DNA Technologies, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Transposagen Biopharmaceuticals, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
OriGene Technologies, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
New England Biolabs
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Dharmacon, Cellecta, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Agilent Technologies
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Applied StemCell, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
9. Section
References
Research Methodology
About Us and Sales Contact
*Browse 31 market data tables and 27 figures on " CRISPR and CAS Gene Market” - Global forecast to 2026”

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report